These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 476367)

  • 1. Depressive classification and prediction of response to phenelzine.
    Paykel ES; Parker RR; Penrose RJ; Rassaby ER
    Br J Psychiatry; 1979 Jun; 134():572-81. PubMed ID: 476367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of phenelzine outome in depressives.
    Paykel ES; Parker RR; Penrose RJ; Rassaby E
    Neuropharmacology; 1978 Dec; 17(12):1055-6. PubMed ID: 745692
    [No Abstract]   [Full Text] [Related]  

  • 5. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
    Quitkin F; Rifkin A; Klein DF
    Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 11. A multiple-dose, controlled study of phenelzine in depression-anxiety states.
    Ravaris CL; Nies A; Robinson DS; Ives JO; Lamborn KR; Korson L
    Arch Gen Psychiatry; 1976 Mar; 33(3):347-50. PubMed ID: 769725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacokinetic factors affecting response to phenelzine.
    Tyrer P; Gardner M; Lambourn J; Whitford M
    Br J Psychiatry; 1980 Apr; 136():359-65. PubMed ID: 6992903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
    [No Abstract]   [Full Text] [Related]  

  • 17. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A; Crook TH
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety.
    Tyrer P; Candy J; Kelly D
    Psychopharmacologia; 1973 Sep; 32(3):237-54. PubMed ID: 4586902
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
    Tyrer P
    J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenelzine and amitriptyline: effects on symptoms of neurotic depression.
    Rowan PR; Paykel ES; Parker RR
    Br J Psychiatry; 1982 May; 140():475-83. PubMed ID: 7049292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.